B/HPIV3/S-6P

N/A

Report date: 2023/09/11 20:05:57

Base Information

Drug NameB/HPIV3/S-6P
Drug Alias NameB/HPIV-3/S-6-P
ClassificationVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionAnti-Coronavirus spike glycoproteinImmunostimulants
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A